The brokerage noted Lupin's gross margin was 75.2 per cent while EBITDA margins hit 29 per cent on the back of a superior US ...

Prabhudas Lilladher recommended accumulate rating on Lupin with a target price of Rs 2500 in its research report dated May 11 ...

Net Sales at Rs 7,474.66 crore in March 2026 up 31.89% from Rs. 5,667.13 crore in March 2025. Quarterly Net Profit at Rs.

The near-term earnings growth may be a challenge for Lupin as they should see impact of competition in their largest portfolio product, gTolvaptan in FY27, adds the brokerage.

Lupin Ltd (BOM:500257) reports robust revenue and profitability growth, while preparing for increased competition and strategic expansions.

Lupin's sales in the US market were at their highest ever. The US market sales were at $371 million compared to $250 million ...

Strong quarterly surge: Net profit rose 89% to ₹1,460 crore in Q4, with revenue up 31.9% and margins improving to 33.3%.

Generic Ravicti is indicated for chronic management of patients with urea cycle disorders that cannot be managed by dietary protein restriction and/or amino acid supplementation alone.

Lupin's first computer-generated adventures loses some of his franchise's romantic aura, but it would take more than that to steal his mojo. First conceived by the manga artist Monkey Punch (aka Katō ...

Ramesh Swaminathan, ED & Global CFO at Lupin, said the company expects margins to remain around 25% for the full year, ...

On Friday, a post on the official X (formerly Twitter) account for the Lupin the 3rd franchise announced a new animated movie set to come out next year. The film, tentatively titled Lupin the IIIrd ...

There is a particular kind of ambition that rarely announces itself loudly. It does not arrive with sleek dining rooms in major cities or celebrity partnerships. Instead, it appears quietly, often at ...